Visitors to Acadia National Park in Maine will no longer be able to enter for free on Martin Luther King Jr. Day or ...
The Jordan Pond Path in Acadia National Park is a scenic 3.3-mile loop with calm shoreline views, views of the famous Bubbles ...
The US Food and Drug Administration (FDA) has granted approval for Acadia Pharmaceuticals’ Daybue Stix (trofinetide).
Friends of Acadia estimates the park lost about $1.75M in entry revenue in October 2025 alone, not to mention the first two ...
Acadia Pharmaceuticals Inc. is rated a Buy for its steady NUPLAZID/DAYBUE franchises & pipeline-driven upside potential. Read ...
A new $100 surcharge for non-U.S. visitors to Acadia and other national parks raises alarm among Bar Harbor businesses. BAR ...
ACADIA Pharmaceuticals generates revenue primarily through the commercialization of NUPLAZID for Parkinson's disease ...
Neuren Pharmaceuticals Limited ( ($AU:NEU) ) has provided an update. Neuren Pharmaceuticals announced that its partner, Acadia Pharmaceuticals, ...
Acadia Healthcare stock fell after revising its 2025 outlook due to higher litigation costs stemming from patient-related ...